Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator ...

Two randomized trials found that intra-arterial urokinase and tenecteplase did not improve functional outcomes after ...

Two randomized trials have shown that the use of adjunctive intra-arterial thrombolytics does not significantly improve outcomes for stroke patients undergoing mechanical thrombectomy.The impact ...

In patients with acute ischemic stroke due to acute intracranial occlusions of the posterior circulation, the use of ...

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

NEW ORLEANS -- Tenecteplase in recent years outpaced alteplase as the stroke thrombolytic of choice at one large hospital system, despite shrinking cost savings, a researcher reported here.

A pioneering drug that can swiftly restore vital blood flow in stroke sufferers is set to save thousands of lives each year. The clot-busting therapy, tenecteplase, has been shown in trials to be ...

According to NICE, Metalyse costs less than alteplase, so could save the NHS millions of pounds when used as a stroke treatment. So-called thrombolytic therapies like alteplase and tenecteplase ...

Get Your Free Sample of The Tenecteplase TNKase Market Report: Are Stroke Cases Triggering Tenecteplase TNKase Market Growth ? Indeed, an escalating number of stroke cases worldwide has been ...